Small peptides mimicking substance P (1-7) and encompassing a C-terminal amide functionality

Neuropeptides

Volumn 42, Issue 1, 2008, Pages 31-37

  Fransson, Rebecca ^a   Botros, Milad ^a   Nyberg, Fred ^a   Lindeberg, Gunnar ^a   Sandström, Anja ^a   Hallberg, Mathias ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Ala scan; Peptidomimetics; SP (1 7); SP1 7; Structure activity relationships (SAR); Substance P; Substance P (1 7)

Indexed keywords

HEPTAPEPTIDE; SUBSTANCE P;

AMIDATION; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; BIOLOGICAL ACTIVITY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; STRUCTURE ACTIVITY RELATION;

AMIDES; ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; LIGANDS; MALE; MASS SPECTROMETRY; MEMBRANES; MOLECULAR MIMICRY; PEPTIDE FRAGMENTS; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; SPECTROPHOTOMETRY, ULTRAVIOLET; SPINAL CORD; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTANCE P;

EID: 38549158455     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2007.11.002     Document Type: Article

References (37)

1. Barnes P.J. Asthma as an axon reflex. Lancet 1 (1986) 242-245
2. 1-7 in the rat spinal cord. Peptides 27 (2006) 753-759
3. Cheng Y., and Prusoff W.H. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50% inhibition (I50) of an enzymatic reaction. Biochem. Pharmacol. 22 (1973) 3099-3108
4. De Araujo J.E., Huston J.P., and Brandao M.L. Opposite effects of substance P fragments C (anxiogenic) and N (anxiolytic) injected into dorsal periaqueductal gray. Eur. J. Pharmacol. 432 (2001) 43-51
5. Eipper B.A., Stoffers D.A., and Mains R.E. The biosynthesis of neuropeptides: peptide alpha-amidation. Annu. Rev. Neurosci. 15 (1992) 57-85
6. Hall M.E., and Stewart J.M. The substance P fragment SP (1-7) stimulates motor behavior and nigral dopamine release. Pharmacol. Biochem. Behav. 41 (1992) 75-78
7. Hallberg M., Le Greves P., and Nyberg F. Neuropeptide processing. In: Lendeckel U., and Hooper N.M. (Eds). Proteases in Biology and Disease. Proteases in the Brain (2005), Springer Science, NY 203-234
8. Hallberg M., and Nyberg F. Neuropeptide conversion to bioactive fragments - an important pathway in neuromodulation. Curr. Protein. Pept. Sci. 4 (2003) 31-44
9. Hasenohrl R.U., Gerhardt P., and Huston J.P. Substance P enhancement of inhibitory avoidance learning: mediation by the N-terminal sequence. Peptides 11 (1990) 163-167
10. Hasenohrl R.U., Souza-Silva M.A., Nikolaus S., Tomaz C., Brandao M.L., Schwarting R.K., and Huston J.P. Substance P and its role in neural mechanisms governing learning, anxiety and functional recovery. Neuropeptides 34 (2000) 272-280
11. Huston J.P., and Hasenohrl R.U. The role of neuropeptides in learning: focus on the neurokinin substance P. Behav. Brain Res. 66 (1995) 117-127
12. Huston J.P., Hasenohrl R.U., Boix F., Gerhardt P., and Schwarting R.K. Sequence-specific effects of neurokinin substance P on memory, reinforcement, and brain dopamine activity. Psychopharmacology (Berl) 112 (1993) 147-162
13. Igwe O.J., Kim D.C., Seybold V.S., and Larson A.A. Specific binding of substance P aminoterminal heptapeptide [SP (1-7)] to mouse brain and spinal cord membranes. J. Neurosci. 10 (1990) 3653-3663
14. Kramer M.S., Cutler N., Feighner J., Shrivastava R., Carman J., Sramek J.J., Reines S.A., Liu G., Snavely D., Wyatt-Knowles E., Hale J.J., Mills S.G., MacCoss M., Swain C.J., Harrison T., Hill R.G., Hefti F., Scolnick E.M., Cascieri M.A., Chicchi G.G., Sadowski S., Williams A.R., Hewson L., Smith D., Carlson E.J., Hargreaves R.J., and Rupniak N.M. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281 (1998) 1640-1645
15. Kreeger J.S., and Larson A.A. Substance P (1-7), a substance P metabolite, inhibits withdrawal jumping in morphine-dependent mice. Eur. J. Pharmacol. 238 (1993) 111-115
16. Lembeck F., and Holzer P. Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn Schmiedebergs Arch. Pharmacol. 310 (1979) 175-183
17. Levine J.D., Dardick S.J., Roizen M.F., Helms C., and Basbaum A.I. Contribution of sensory afferents and sympathetic efferents to joint injury in experimental arthritis. J. Neurosci. 6 (1986) 3423-3429
18. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275
19. Mantyh C.R., Gates T.S., Zimmerman R.P., Welton M.L., Passaro Jr. E.P., Vigna S.R., Maggio J.E., Kruger L., and Mantyh P.W. Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by arterioles, venules, and lymph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn disease. Proc. Natl. Acad. Sci. USA 85 (1988) 3235-3239
20. Marchand J.E., Hershman K., Kumar M.S., Thompson M.L., and Kream R.M. Disulfiram administration affects substance P-like immunoreactive and monoaminergic neural systems in rodent brain. J. Biol. Chem. 265 (1990) 264-273
21. Nawa H., Hirose T., Takashima H., Inayama S., and Nakanishi S. Nucleotide sequences of cloned cDNAs for two types of bovine brain substance P precursor. Nature 306 (1983) 32-36
22. Nikolaus S., Huston J.P., and Hasenohrl R.U. Anxiolytic-like effects in rats produced by ventral pallidal injection of both N- and C-terminal fragments of substance P. Neurosci. Lett. 283 (2000) 37-40
23. Nyberg F., and Hallberg M. Peptide conversion - a potential pathway modulating G-protein signaling. Curr. Drug Targets 8 (2007) 147-154
24. Nyberg F., and Terenius L. Enzymatic inactivation of neuropeptides. Degradation of Bioactive Substances. Physiology and Pathophysiology (1991), CRC Press Inc., NY 189-200
25. Persson S., Le Greves P., Thornwall M., Eriksson U., Silberring J., and Nyberg F. Neuropeptide converting and processing enzymes in the spinal cord and cerebrospinal fluid. Prog. Brain Res. 104 (1995) 111-130
26. Sakurada C., Watanabe C., and Sakurada T. Occurrence of substance P (1-7) in the metabolism of substance P and its antinociceptive activity at the mouse spinal cord level. Methods Find. Exp. Clin. Pharmacol. 26 (2004) 171-176
27. Sakurada T., Le Greves P., Stewart J., and Terenius L. Measurement of substance P metabolites in rat CNS. J. Neurochem. 44 (1985) 718-722
28. Santarelli L., Gobbi G., Debs P.C., Sibille E.T., Blier P., Hen R., and Heath M.J. Genetic and pharmacological disruption of neurokinin 1 receptor function decreases anxiety-related behaviors and increases serotonergic function. Proc. Natl. Acad. Sci. USA 98 (2001) 1912-1917
29. Skidgel R.A., Engelbrecht S., Johnson A.R., and Erdos E.G. Hydrolysis of substance P and neurotensin by converting enzyme and neutral endopeptidase. Peptides 5 (1984) 769-776
30. Stewart J.M., Hall M.E., Harkins J., Frederickson R.C., Terenius L., Hokfelt T., and Krivoy W.A. A fragment of substance P with specific central activity: SP (1-7). Peptides 3 (1982) 851-857
31. Tomaz C., Silva A.C., and Nogueira P.J. Long-lasting mnemotropic effect of substance P and its N-terminal fragment (SP1-7) on avoidance learning. Braz. J. Med. Biol. Res. 30 (1997) 231-233
32. Von Euler U.S., and Gaddum J.H. An unidentified depressor substance in certain tissue extracts. J. Physiol. 72 (1931) 74-87
33. Wiktelius D., Khalil Z., and Nyberg F. Modulation of peripheral inflammation by the substance P, N-terminal metabolite substance P1-7. Peptides 27 (2006) 1490-1497
34. Yokosawa H., Endo S., Ogura Y., and Ishii S. A new feature of angiotensin-converting enzyme in the brain: hydrolysis of substance P. Biochem. Biophys. Res. Commun. 116 (1983) 735-742
35. Zhou Q., Frandberg P.A., Kindlundh A.M., Le Greves P., and Nyberg F. Substance P (1-7) affects the expression of dopamine D2 receptor mRNA in male rat brain during morphine withdrawal. Peptides 24 (2003) 147-153
36. Zhou Q., Liu Z., Ray A., Huang W., Karlsson K., and Nyberg F. Alteration in the brain content of substance P (1-7) during withdrawal in morphine-dependent rats. Neuropharmacology 37 (1998) 1545-1552
37. Zubrzycka M., and Janecka A. Substance P: transmitter of nociception (Minireview). Endocr. Regul. 34 (2000) 195-201